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Abstract
Background: Herpes simplex viruses (HSVs) rapidly shut off macromolecular synthesis in host cells. In contrast,
global microarray analyses have shown that HSV infection markedly up-regulates a number of host cell genes that
may play important roles in HSV-host cell interactions. To understand the regulatory mechanisms involved, we
initiated studies focusing on the zinc finger transcription factor insulinoma-associated 1 (INSM1), a host cell protein
markedly up-regulated by HSV infection.
Results: INSM1 gene expression in HSV-1-infected normal human epidermal keratinocytes increased at least 400-
fold 9 h after infection; INSM1 promoter activity was also markedly stimulated. Expression and subcellular
localization of the immediate early HSV protein ICP0 was affected by INSM1 expression, and chromatin
immunoprecipitation (ChIP) assays revealed binding of INSM1 to the ICP0 promoter. Moreover, the role of INSM1 in
HSV-1 infection was further clarified by inhibition of HSV-1 replication by INSM1-specific siRNA.
Conclusions: The results suggest that INSM1 up-regulation plays a positive role in HSV-1 replication, probably by
binding to the ICP0 promoter.
Background
Herpes simplex virus types 1 (HSV-1) and 2 (HSV-2)
are large DNA viruses with genomes consisting of at
least 74 genes [1], which are classified into four groups
with respect to their order of expression on the entry of
HSV into the host cell. Immediate early (IE) genes are
transcribed without prior viral protein synthesis. Early
genes are expressed before the onset of viral DNA
synthesis and require IE gene expression. Expression of
delayed early genes is partially dependent on viral DNA
synthesis, but that of late or true late genes is comple-
tely dependent on viral DNA synthesis. The cascade of
HSV gene expression is tightly regulated by viral and
cellular factors [2-6].
HSV infection markedly affects expression of host cell
genes. The HSV genome encodes a virion-associated
endonuclease UL41 that degrades viral and cellular
mRNA early in infection. The IE protein ICP27 also
inhibits cellular gene expression by blocking mRNA
splicing [7]. Although the high level of viral transcrip-
tion appears to overcome the effect of these proteins,
host cell protein synthesis is strongly suppressed early in
HSV infection. However, microarray analysis has shown
that HSV-infected cells express high levels of a signifi-
cant number of cellular genes [8]. We have shown that
transcript levels of the cellular genes ZSCAN4, ZNF342,
and HBA2 increased by more than 100-fold in both
HSV-1- and HSV-2-infected HEp-2 cells [8]. Although
whether enhanced expression of these three genes at the
transcriptional level corresponds to increased expression
of their gene products is unclear, such marked host cell
responses may reveal novel regulatory mechanisms
involved in HSV replication.
Cells of the developing central and peripheral nervous
system as well as endocrine cells of the developing pan-
creas and intestine express insulinoma-associated 1
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specifically, INSM1 gene expression is highly restricted
to fetal pancreatic and brain tissues [10-14]. Since
INSM1 is also highly expressed in tumors of neuroendo-
crine origin, its promoter could serve as a tumor-speci-
fic target for gene therapy for neuroendocrine tumors
[15-17]. Recent studies have shown that INSM1 is a cru-
cial component of the transcriptional network that con-
trols differentiation of the sympatho-adrenal lineage
[18], and that INSM1 is involved in the generation and
expansion of basal progenitors in the developing neocor-
tex [19].
In the present study, we found that INSM1 gene
expression was markedly stimulated by HSV-1 and
HSV-2 infections of normal human epidermal keratino-
cytes (NHEK) and HaCaT cells. We also report the
effects of INSM1 on expression and distribution of the
IE protein ICP0 and a possible role of INSM1 in HSV-1
replication.
Results
Microarray analysis of cellular transcriptional responses to
HSV-1 and HSV-2 infections
We previously reported that HSV-1 and HSV-2 infec-
tions markedly increased mRNA levels of specific cellu-
lar genes in HEp-2 cells [8]. Since the HEp-2 cell line is
derived from a tumor, responses of HEp-2 cells to HSV
infections may differ from those of non-transformed
cells. Therefore, we performed global microarray analy-
sis of NHEK cells that were mock infected or infected
with wild-type (WT) HSV-1, WT HSV-2, and their US3
mutants. While US3 is not essential for viral replication
in vitro, the protein kinases encoded by the US3 genes
of HSV-1 and HSV-2 have been shown to play impor-
tant roles in various aspects of viral replication and
pathogenicity, including regulation of apoptosis and sig-
nal transduction and virion maturation [20-24]. We thus
examined the transcriptional responses of cells infected
with the US3 mutants. Table 1 shows cellular genes
whose mRNA levels increased by at least 4-fold 9 h
after infection. Among the 54,765 probe sets examined,
levels of 189 transcripts increased by at least 4-fold in
infected NHEK cells and those of 108 transcripts
increased in common in both NHEK and HEp-2 cells.
In NHEK cells, INSM1 expression was always highly up-
regulated in all cases. Our microarray analysis showed
that the level of INSM1 mRNAs increased by at least
400-fold 9 h after infection in HSV-infected cells com-
pared with mock-infected cells. Although the extent of
increase was higher in US3 mutant-infected cells than in
WT-infected cells, the mechanism remains unclear. The
marked up-regulation of INSM1 by HSV infections was
confirmed by reverse transcription (RT)-PCR analysis of
NHEK, HaCaT, and HEp-2 cells (Figure 1). Moreover,
we found that such up-regulation was not induced by
UV-inactivated HSV-1 (Figure 1B). The INSM1 gene,
similar to most HSV genes, lacks introns [25]. INSM1
has recently been shown to bind cyclin D1 and play an
important role in switching cells between cellular prolif-
eration and differentiation pathways [26]. Therefore, we
focused here on HSV-induced INSM1 up-regulation.
HSV infection stimulates human INSM1 promoter activity
To investigate the effect of HSV infection on INSM1
promoter-dependent expression, reporter gene assays
were performed. Figure 2A shows a schematic repre-
s e n t a t i o no fh u m a nI N S M 1p r o m o t e rr e g i o n( - 4 4 1t o
+26 bp), which was amplified by PCR using DNA
extracted from HEp-2 cells, confirmed by sequence
analysis, and cloned into the pGL3 luciferase reporter
vector. HaCaT and HEp-2 cells were transfected with
this construct or empty vector DNA and then infected
with WT HSV-1 at a multiplicity of infection (MOI) of
3 plaque-forming units (PFU)/cell 24 h after transfec-
tion. The cells were collected 9 h after infection.
INSM1 promoter activity increased approximately 350-
fold in infected HaCaT cells (Figure 2B) and 80-fold in
infected HEp-2 cells (Figure 2C). In infected HEp-2
and HaCaT cells, luciferase activity rapidly increased
until 12 h after infection (data not shown). Extracts
prepared from cells infected with UV-inactivated HSV-
1 failed to support INSM1 promoter activity. These
observations indicate that HSV infection activates the
INSM1 promoter.
Subcellular localization of human full-length INSM1
(INSM1-FL) and mutant proteins
We next constructed human INSM1 expression vectors
to investigate the effects of INSM1 on HSV replication.
Human INSM1 is a 58-kDa protein that contains five
zinc finger motifs in its C-terminal domain (Figure 3A).
The N-terminal domain contains a putative nuclear
localization signal (NLS) and proline-rich domains that
interact with cyclin D1 [26]. Thus, the expression vec-
tors of INSM1 N- and C-terminal domains were con-
structed and used along with a INSM1-FL construct to
transfect HEp-2 cells. The cells were subjected to Wes-
tern blot analysis 24 h after transfection. As determined
by Western blot analysis, the anti-INSM1 antibody
raised against the human INSM1 C-terminal peptides
(NP_002187, amino acid residues 393-442) reacted
weakly with a 60-kDa band in INSM1-FL-transfected
cells and a 40-kDa band in INSM1-C-transfected cells
(Figure 3B). Both bands were easily detected by the anti-
Myc antibody because of the Myc-tag epitope expressed
by the constructs. Although a 50-kDa band was detected
in all cases, it appeared to be non-specific because the
apparent molecular size was smaller than the expected
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Representative
Public ID
a
Gene
Symbol
Gene Title Fold change
b Gene Ontology
Biological Process
HSV-1 HSV-2
WT ΔUS3 WT ΔUS3
NM_005083 U2AF1L1 U2 small nuclear RNA auxillary factor 1-like 1 4.0 13.0 5.3 7.5 —
AV712346 REEP5 Receptor accessory protein 5 9.8 11.3 11.3 9.8 —
AK091308 NARG1 NMDA receptor regulated 1 26.0 59.7 36.8 19.7 —
AW613101 KCNQ1OT1 KCNQ1 overlapping transcript 1 32.0 45.3 42.2 78.8 —
AW014728 FLJ39575 hypothetical protein FLJ39575 90.5 111.4 78.8 207.9 —
AL359567 IGSF4 Immunoglobulin superfamily, member 4 8.0 17.1 10.6 7.5 immune response
NM_000594 TNF tumor necrosis factor (TNF superfamily, member
2)
21.1 34.3 8.6 11.3 immune response
AW135003 API5 Apoptosis inhibitor 5 4.3 6.1 4.6 5.7 apoptosis
AW511239 RHOT1 Ras homolog gene family, member T1 4.9 6.1 6.5 8.6 apoptosis
AA005430 CROP Cisplatin resistance-associated overexpressed
protein
7.0 13.0 13.0 9.8 apoptosis
NM_006538 BCL2L11 BCL2-like 11 (apoptosis facilitator) 39.4 29.9 19.7 39.4 apoptosis
NM_006910 RBBP6 retinoblastoma binding protein 6 4.0 6.5 6.1 6.1 cell cycle
NM_000076 CDKN1C cyclin-dependent kinase inhibitor 1C (p57, Kip2) 4.9 5.7 8.0 7.0 cell cycle
X07868 IGF2 insulin-like growth factor 2 (somatomedin A) 6.1 7.0 5.7 7.5 cell cycle
NM_015675 GADD45B growth arrest and DNA-damage-inducible, beta 12.1 14.9 14.9 34.3 cell cycle
NM_003914 CCNA1 cyclin A1 13.0 21.1 13.0 14.9 cell cycle
BE348555 PDZK1 PDZ domain containing 1 4.0 9.2 4.6 6.5 signal transduction
NM_005204 MAP3K8 mitogen-activated protein kinase kinase kinase 8 4.0 12.1 4.6 6.5 signal transduction
NM_003328 TXK TXK tyrosine kinase 5.7 5.3 9.8 10.6 signal transduction
NM_014823 WNK1 WNK lysine deficient protein kinase 1 6.1 5.3 9.8 7.0 signal transduction
AI684439 GRAP GRB2-related adaptor protein 13.9 8.6 6.1 16.0 signal transduction
NM_018390 PLCXD1 phosphatidylinositol-specific phospholipase C, X
domain containing 1
11.3 34.3 17.1 19.7 signal transduction
AF069506 RASD1 RAS, dexamethasone-induced 1 111.4 104.0 111.4 207.9 signal transduction
NM_004692 INA internexin neuronal intermediate filament protein,
alpha
6.5 9.8 4.6 4.6 cell adhesion and
cytoskeleton
AI668588 SPTAN1 Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) 16.0 27.9 26.0 26.0 cell adhesion and
cyctoskeleton
NM_005382 NEFM neurofilament, medium polypeptide 150kDa 29.9 36.8 26.0 55.7 cell adhesion and
cytoskeleton
U26662 NPTX2 neuronal pentraxin II 45.3 52.0 32.0 34.3 cell communication
NM_002105 H2AFX H2A histone family, member X 10.6 13.9 7.5 13.0 DNA / chromosome
NM_003655 CBX4 chromobox homolog 4 (Pc class homolog,
Drosophila)
24.3 29.9 14.9 36.8 DNA/chromosome
AL832081 ZNF131 Zinc finger protein 131 4.3 7.0 6.1 9.8 transcription
T79183 JAZF1 JAZF zinc finger 1 5.7 4.9 7.5 8.6 transcription
D42040 BRD2 bromodomain containing 2 6.1 9.2 6.1 8.6 transcription
NM_001452 FOXF2 forkhead box F2 6.5 14.9 11.3 16.0 transcription
NM_005904 SMAD7 SMAD family member 7 7.0 9.8 7.0 12.1 transcription
AF193855 ZIC2 Zic family member 2 (odd-paired homolog,
Drosophila)
13.0 55.7 34.3 68.6 transcription
NM_001674 ATF3 activating transcription factor 3 13.9 16.0 36.8 26.0 transcription
AI459175 KLF3 Kruppel-like factor 3 (basic) 14.9 18.4 16.0 14.9 transcription
NM_004405 DLX2 distal-less homeobox 2 17.1 24.3 13.9 42.2 transcription
AW274658 ING1 Inhibitor of growth family, member 1 19.7 12.1 10.6 24.3 transcription
NM_002166 ID2 inhibitor of DNA binding 2, dominant negative
helix-loop-helix protein
24.3 22.6 19.7 42.2 transcription
NM_002448 MSX1 msh homeobox 1 59.7 84.4 48.5 128.0 transcription
NM_152677 ZSCAN4 zinc finger and SCAN domain containing 4 97.0 362.0 55.7 147.0 transcription
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Page 3 of 15size of human INSM1-FL and the band intensity did not
change after HSV infections.
Transfected cells were fixed, reacted with anti-human
INSM1 and anti-Myc antibodies, and examined by con-
focal laser microscopy (Figure 3C). In INSM1-FL-trans-
fected cells, specific INSM1 fluorescence was detected
exclusively in the nucleus. In INSM1-N-transfected
cells, no specific fluorescence was detected when exam-
ined with the anti-INSM1 antibody. However, immuno-
fluorescence staining using the anti-Myc antibody
revealed that INSM1-N was localized in the nucleus in a
majority of cells and in the cytoplasm of some cells. In
contrast, INSM1-C that lacked a putative NLS predomi-
nantly localized in the cytoplasm, as expected.
Effect of INSM1 and its mutant proteins on expression
and subcellular localization of ICP0
INSM1-binding sequences have been identified as T
G/
T
C/T
C/T
T/AGGGG
G/TC
G/A [27]. To identify consen-
sus sequences for INSM1 binding in HSV-1 (17
+,
X14112) and HSV-2 (HG52, Z86099) genomes, their
complete genomic sequences were analyzed using
GENETYX version 8 (Software Development Co.,
Tokyo, Japan). The results showed that both HSV-1
and HSV-2 genomes contain several INSM1-binding
sequences, but only one sequence was present in the
upstream promoter region o ft h es p e c i f i cg e n eI C P 0 ,
suggesting that ICP0 could be an INSM1 target.
Therefore, we examined the effect of INSM1 on
expression and localization of ICP0 in HSV-1-infected
cells. The cells were transfected with each INSM1
expression vector and infected with HSV-1 at MOI of
3 PFU/cell 24 h after transfection. The cells were then
fixed at appropriate times after infection and processed
for visualization by immunofluorescent confocal laser
microscopy (Figure 4). ICP0 signals were detected as
dots in the nucleus 4 h after infection in empty vector-
transfected cells, as expected (Figure 4A). The distribu-
tion pattern of ICP0 in INSM1-FL-expressing cells was
similar to that in mock-transfected cells, but the inten-
sity of ICP0-specific fluorescence appeared to be
higher in INSM1-FL-expressing cells than in non-
expressing cells. Such augmented expression of ICP0
in INSM1-FL-expressing cells was more clearly
observed in Vero and HaCaT cells (Figure 4B and 4C).
Interestingly, ICP0 expression was strongly suppressed
in most INSM1-N-expressing cells in contrast to
INSM1-C-expressing cells (Figure 4A). Nuclear ICP0 is
known to translocate to the cytoplasm late in HSV
infection [28]. In fact, ICP0 was predominantly locali-
zaed in the cytoplasm of mock-transfected cells 18 h
after infection (Figure 4D). In INSM1-FL-expressing
cells, however, ICP0 remained in the nucleus, indicat-
ing that INSM1 can inhibit the translocation of ICP0
to the cytoplasm late in infection.
We also examined the effect of INSM1 on expression
and subcellular localization of the single-strand DNA-
binding protein ICP8 (Figure 5). No evidence showed
Table 1 Human genes induced by HSV infection of NHEK cells at 9h after infection (Continued)
AA761573 ZNF342 zinc finger protein 342 128.0 256.0 111.4 294.1 transcription
NM_002196 INSM1 insulinoma-associated 1 445.7 776.0 955.4 1782.9 transcription
AI906424 HNRPM Heterogeneous nuclear ribonucleoprotein M 4.3 5.7 6.5 11.3 RNA / translation
AI445255 SFRS3 Splicing factor, arginine/serine-rich 3 13.0 14.9 14.9 21.1 RNA / translation
R17062 PABPC1 Poly(A) binding protein, cytoplasmic 1 32.0 39.4 48.5 90.5 RNA / translation
BF195994 PIAS2 Protein inhibitor of activated STAT, 2 4.3 5.7 4.6 9.2 protein folding and
modification
U56725 HSPA2 heat shock 70kDa protein 2 5.7 8.6 4.0 5.7 protein folding and
modification
AU158573 ABHD5 Abhydrolase domain containing 5 13.0 18.4 11.3 19.7 protein folding and
modification
NM_000104 CYP1B1 cytochrome P450, family 1, subfamily B,
polypeptide 1
6.1 6.5 13.0 18.4 development
NM_001529 HHEX homeobox, hematopoietically expressed 17.1 48.5 97.0 68.6 development
NM_002405 MFNG MFNG O-fucosylpeptide 3-beta-N-
acetylglucosaminyltransferase
4.0 8.0 4.6 8.6 developmental process
NM_000361 THBD thrombomodulin 9.8 11.3 5.7 8.6 biological regulation
NM_000499 CYP1A1 cytochrome P450, family 1, subfamily A,
polypeptide 1
4.3 4.9 5.3 7.5 cellular metabolism
AI625747 ADRB1 adrenergic, beta-1-, receptor 6.1 18.4 7.5 10.6 cellular metabolism
NM_003895 SYNJ1 synaptojanin 1 6.5 13.0 7.5 11.3 cellular metabolism
NM_000558 HBA1 hemoglobin, alpha 1 55.7 84.4 34.3 137.2 transport
a GeneBank accession No. corresponds to sequence to which the Affymetrix U133 plus 2 probe set was designed.
b Fold change was calculated by comparison to values obtained from the mock-infected cells.
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Page 4 of 15that INSM1-FL or INSM1-C expression affected ICP8
expression, but ICP8 expression appeared to be sup-
pressed in INSM1-N-expressing cells. In HSV-1-infected
cells, INSM1-FL localized to the replication compart-
ment late in infection. Furthermore, subcellular localiza-
tion of INSM1-N and INSM1-C was found to be
affected by HSV-1 infection, with both mutant proteins
co-localizing with ICP8 in the nucleus.
These observations suggest that INSM1 expression
enhanced ICP0 expression early in infection but inhib-
ited the translocation of ICP0 to the cytoplasm late in
infection, and that ICP0 expression was suppressed by
INSM1-N even during the late phase. However, we have
so far failed to show a significant difference in ICP0
expression between INSM1-transfected or mock-trans-
fected cells by Western blot analysis, probably because
of low transfection efficiency.
Effect of INSM1 on ICP0 promoter activity
As described above, the ICP0 promoter contains the
INSM1-binding consensus sequence T
G/T
C/T
C/T
T/
AGGGG
G/TC
G/A [27] and several potential INSM1-
binding sequences, TNNNNGGGGNCN (Figure 6A). In
addition, our observations showed that INSM1 expres-
sion significantly modulated ICP0 expression in HSV-1-
infected cells. Therefore, we wanted to determine the
effect of INSM1 on the ICP0 promoter by luciferase
reporter gene assays. Because the ICP0 promoter
A.
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M
HSV-1 HSV-2
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300
bp
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INSM1
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Figure 1 INSM1 expression in HSV-infected cells. (A) NHEK cells
were infected with wild-type (WT) HSV-1, WT HSV-2, and their US3
deletion mutants (multiplicity of infection, MOI = 3), and total RNA
was extracted 9 h after infection. INSM1 mRNA was amplified by RT-
PCR as described in Methods. GAPDH was used as a control. Data
represent two independent experiments. (B) HaCaT cells were
infected with HSV-1 or UV-inactivated HSV-1 (MOI = 3), and total
RNA was extracted for RT-PCR at 3 and 9 h after infection. (C) HEp-2
cells were infected with WT HSV-1, WT HSV-2, and their US3
deletion mutants (MOI = 3), and total RNA was extracted for RT-PCR
at 9 h after infection.
B.
C.
A. 
Figure 2 Effect of HSV infection on INSM1 promoter-directed
luciferase activities. (A) Schematic representation of the INSM1
promoter region from position -441 to +26. Predicted transcription
factor binding sites are as follows: E (E box, 5′-CATTTG-3′,5 ′-
CACGTG-3′, and 5′-CATCTG-3′), S (SP1-binding site, 5′-
GGGGCCGGGC-3′ and 5′-CGGGCGGGC-3′), and I (INSM1-binding site,
5′-CTCCAGGGGAAGC-3′). (B and C) Luciferase reporter assays. HaCaT
(B) and HEp-2 (C) cells were infected with WT HSV-1 and UV-
inactivated HSV-1 (MOI = 3) and harvested 9 h after infection.
Luciferase activity was measured as described in Methods. The
results are shown as means ± standard deviation (SD).
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C.
FL
N
C
INSM1 Myc merge
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Figure 3 Expression of INSM1 and INSM1 deletion mutants. (A) Schematic diagram of INSM1 domain structure. INSM1 has two proline-rich
domains (P, amino acid residues 43-58 and 75-84), one NLS (N, amino acids residues 221-246) and five C2H2 zinc finger motifs (Z). HEp-2 cells
were transfected with FL or deletion mutant INSM1 expression vectors and incubated for 24-48 h prior to analysis by Western blotting (B) and
confocal microscopy (C). The positions of mutant proteins detected by polyclonal antibodies are shown. Anti-Myc rabbit polyclonal antibody (B,
right) and anti-INSM1 rabbit polyclonal antibody (B, left) were used to detect full-length and mutant proteins, respectively. The asterisk indicates
a non-specific band.
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Page 6 of 15contains binding sites for the Oct-1 protein complex
containing host cell factor (HCF), and the HSV virion-
associated transactivator VP16 [29,30] and the transcrip-
tion of the ICP0 gene is highly activated by VP16 [31],
we examined the effect of INSM1 on ICP0 promoter
activity in the presence of VP16. In fact, the ICP0 pro-
moter exhibited extremely weak activity in the absence
of VP16 when examined by reporter assays in HEp-2
cells (data not shown); therefore, the effect of INSM1
was measured under conditions in which cells were co-
transfected with a VP16 expression vector (Figure 6B).
Luciferase activity was enhanced approximately 20-fold
by the VP16 expression vector and was further augmen-
ted by INSM1 expression although the addition of an
empty vector also increased the luciferase activity to
some extent. The difference between the INSM1 expres-
sion vector and empty vector was statistically significant
and repeatedly observed in three independent experi-
ments. However, the addition of increased amounts of
the INSM1 expression vector suppressed luciferase
empty
FL
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FL
FL
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FL
N
FL
Myc
Myc
Myc
Myc
Myc
Myc
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ICP0
ICP0
ICP0
ICP0
ICP0
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Myc
Myc
A. HEp-2, p.i.4h B. Vero, p.i.4h
C. HaCaT, p.i.4h
D. HEp-2, p.i.18h
Figure 4 Expression and localization of ICP0 in INSM1-expressing cells.H E p - 2(A and D), Vero (B), and HaCaT (C) cells were transfected
with plasmids encoding Myc-tagged full-length INSM1 (INSM1-FL) and deletion mutants (N and C). At 20-24 h after transfection, cells were
infected with HSV-1(F) (MOI = 3), fixed at 4 h (A, B and C) or 18 h (D) after infection, and reacted with anti-Myc and anti-ICP0 antibodies as
described in Methods.
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Page 7 of 15expression. A similar trend was observed in HEp-2 and
HaCaT cells. These results indicate that the ICP0 pro-
moter can be activated by INSM1 under specific
conditions.
INSM1 binds the ICP0 promoter
We performed ChIP assays to determine whether
INSM1 binds the ICP0 promoter. Thus, HEp-2 cells
were transfected with empty and INSM1-FL vectors,
infected with HSV-1(F) 48 h after transfection, fixed
with formaldehyde 7 h after infection, and processed for
ChIP assays (see Methods). Chromatin solution was
incubated with the anti-Myc antibody or control IgG,
and the immunoprecipitated complexes were analyzed
by PCR using ICP0 promoter-specific primers and
ICP27 promoter-specific primers as controls. Figure 7
shows that ICP0 promoter sequences were amplified by
chromatin complexes precipitated by anti-Myc antibo-
d i e s ,b u tn o tb yn o r m a lI g G .T h eI C P 2 7p r o m o t e r
sequence was not detectably amplified in either case.
Therefore, these results indicate that INSM1 selectively
binds the ICP0 promoter.
infected
Figure 5 Subcellular localization of ICP8 in INSM1-expressing cells.H E p - 2c e l l sw e r et r a n s f e c t e dw i th plasmids encoding Myc-tagged
INSM1-FL and deletion mutants (N and C). At 20-24 h after transfection, cells were infected with HSV-1(F) (MOI = 3), fixed 18 h after infection,
and reacted with anti-Myc and anti-ICP8 antibodies as described in Methods.
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Figure 6 Effect of HSV infection on ICP0 promoter-derived luciferase activities. (A) Graphical representation of the nucleotide sequences of
the ICP0 promoter region from position -834 to +145. The HSV-1 ICP0 promoter has several potential INSM1-binding sites (red, INSM1-binding
consensus site, 5′-TCCCCGGGGACG-3′; gray, INSM1-like binding site, 5′-TNNNNGGGGNCN-3′). The binding sites of well-known transcription factors
are as follows: blue, Oct-1/VP16 binding site, 5′-ATGCTAATGATAT-3′. (B) HEp-2 cells were transfected with plasmid DNAs containing reporter and
effector genes. Luciferase activity was measured as described in Methods. The results are shown as means ± SD, *P < 0.05 (Student’s t test)
relative to the empty vector (EF).
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Page 9 of 15INSM1-specific siRNA inhibits HSV replication
The above observations lead us to conclude that
INSM1 expression enhances HSV-1 replication. To
better support this conclusion, the effect of INSM1
knockdown on the efficiency of viral replication was
examined using siRNA technology. INSM1-specific
siRNA markedly reduced the level of INSM1 mRNA,
but scramble siRNA did not (Figure 8A). Cells were
mock-transfected or transfected with either scrambled
siRNA or siRNA specific for INSM1, and then infected
with HSV-1 at MOI of 0.01 PFU/cell 48 h after trans-
fection. At 48 h after infection, culture medium was
harvested and assayed for viral infectivity and sub-
jected to Western blot analysis. As shown in Figure 8B
and 8C, pretreatment of cells with INSM1-specific
siRNA suppressed HSV-1 replication as well as the
production of the major capsid protein VP5. These
results indicate that INSM1 supports HSV-1 replica-
tion in HEp-2 cells.
Discussion
The transcription factor INSM1 plays an important role
in developing neuroendocrine tissues and the nervous
system in mammals [9]. The expression pattern of
INSM1 is restricted to the fetal tissues and silenced in
adult tissues [9]. However, the INSM1 gene is known to
be reactivated in neuroendocrine tumors [15,32]. Our
present study shows that transcriptional expression of
t h eI N S M 1g e n ew a sm a r k e d l yu p - r e g u l a t e db yH S V - 1
or HSV-2 infection. This marked increase was observed
in normal and human tumor cell lines. In addition, we
employed an INSM1 promoter-driven luciferase expres-
sion vector to confirm that INSM1 promoter activity
was markedly elevated by infection with HSV and not
with UV-inactivated HSV, strongly suggesting that HSV
gene expression is necessary for activating the INSM1
promoter. Since an immediate early gene product, ICP4
is well known to activate the expression of cellular
genes, it is a possible candidate for a transactivator of
the INSM1 gene. Previous studies have shown that ICP4
forms a tripartite complex with TFIIB and TATA bind-
ing protein (TBP) on DNA and interacts with TBP asso-
ciated factor 250 (TAF250) [33,34]. ICP4 promotes the
formation of transcription preinitiation complex by
ICP0
ICP27
INSM1 empty
300
200
400
300
bp M
Figure 7 Binding of INSM1 to the ICP0 promoter. ChIP assays
were performed as described in Methods. INSM1-DNA complexes
were incubated with the anti-Myc antibody or normal rabbit IgG.
The precipitated and genomic DNAs (input) were subjected to PCR
amplification using primers specific for both ICP0 and ICP27
promoters. Data represent two independent experiments.
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Figure 8 Effect of INSM1-specific siRNA on HSV-1 replication.
HEp-2 cells were transfected with siRNA specific for human INSM1
and a scrambled oligomer. At 24 h after transfection, HEp-2 cells
were infected with HSV-1(F) (MOI = 1), and total RNA was extracted
6 h after infection. INSM1 mRNA was amplified by RT-PCR as
described in Methods. GAPDH was used as a control (A).A t4 8h
after transfection, cells were infected with HSV-1(F) (MOI = 0.01),
and the amount of the major capsid protein VP5 (B) and infectivity
(C) were measured at 48 h after infection by Western blotting and
plaque assays, respectively. Results of viral titers are shown as mean
± SD. *P < 0.05 (Student’s t test) relative to the scrambled control
oligomer.
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fore, it is possible that ICP4 could transactivate INSM1.
VP16 could also be involved in the activation of the
ISNM1 promoter. However, the exact mechanism by
which HSV infection activates the INSM1 promoter
remains to be determined.
The INSM1 gene, similar to most HSV genes, lacks
introns [25]. The IE protein ICP27 inhibits host cell
mRNA splicing, resulting in the accumulation of
unspliced transcripts in the nucleus and mediates RNA
export of intronless mRNA. Therefore, we expected that
the INSM1 gene product could be detected in HSV-
infected cells but failed to detect it, probably because of
the low specificity and reactivity of the anti-INSM1 anti-
body used. Currently, whether up-regulation of INSM1
mRNA in HSV-infected cells result in the production of
functional INSM1 is unclear.
We constructed the expression vectors of INSM1-FL
a n di t sN -a n dC - t e r m i n a ld o m a i n sf u s e di nt h ef r a m e
with the Myc-tag epitope. Using these expression vec-
tors, we observed that INSM1 expression enhanced
ICP0 expression early in infection. Nucleotide sequence
analysis showed that the upstream promoter region of
ICP0 contained an INSM1-binding consensus sequence
and several potential INSM1-binding sequences, sug-
gesting that INSM1 directly exerted its effect on ICP0
expression by binding its promoter region. In fact, our
reporter gene assays showed that INSM1 significantly
stimulated the ICP0 promoter in the presence of the vir-
ion-associated transactivator VP16. However, the addi-
tion of increased amounts of the INSM1 expression
vector suppressed luciferase expression. When added at
high concentrations, VP16 might attract Oct-1 and HCF
to vector sites instead of ICP0 promoter. It seems likely
that some kind of swamping would be induced in the
expression vectors. In this study, we also showed that
INSM1 binds the ICP0 promoter but not the ICP27
promoter. Taken together, our results strongly suggest
that INSM1 regulates ICP0 expression by binding the
ICP0 promoter. However, INSM1 could also indirectly
modulate ICP0 expression by inducing expression of
cellular factors involved in ICP0 expression.
Based on the amino acid sequences, INSM1 can be
functionally divided into N- and C-terminal regions [9].
The C-terminal region of human INSM1 contains five
zinc finger domains that mediate DNA binding activity.
The N-terminal region contains a putative NLS and two
proline-rich domains that can serve as protein-protein
interacting domains. In fact, the proline-rich N-terminal
portion of INSM1 has recently been shown to specifi-
cally bind cyclin D1, a key cell cycle regulator, and that
through this interaction, INSM1 interrupts the interac-
tion between cyclin D1 and cyclin-dependent kinase 4
(CDK4), which subsequently inhibits Rb phosphorylation
[26]. HSV induces Rb hypophosphorylation in infected
cells, and it has been suggested that the inhibition of
although the precise mechanism remains unclear [36].
We therefore postulate that INSM1 can directly and
indirectly modulate transcriptional expression of ICP0.
Subcellular localization of ICP0 was markedly affected
by INSM1 overexpression late in infection. During the
IE phase of infection, ICP0, a RING finger E3 ubiquitin
ligase, is exclusively nuclear and acts as a nuclear regu-
lator of HSV mRNA synthesis [37]. However, ICP0
translocates to the cytoplasm during the early phase
[28], and a recent study showed that cytoplasmic ICP0
plays a role in virion maturation and/or egress by dis-
mantling the host cell’s microtubules networks [38]. Our
observations showed that INSM1 inhibits the transloca-
tion of ICP0 to the cytoplasm. Recently, Kalamavoki and
Riozman showed that inhibition of CDK4 kinase activity
inhibits the translocation of ICP0 from the nucleus to
the cytoplasm in infected cells [39]. INSM1 can indir-
ectly inhibit CDK4 function through its interaction with
cyclin D1, and therefore, the N-terminal proline-rich
domains of INSM1 may be involved in this phenom-
enon. In the late stage of the replication cycle, INSM1
may inhibit virus replication. However, this effect may
be an artifact caused by INSM1 overexpression in trans-
fected cells.
Conclusions
In summary, our study clearly demonstrates that HSV
infection up-regulates the expression of INSM1 which
can regulate expression and localization of the IE pro-
tein ICP0. Since the INSM-specific siRNA inhibited the
growth of HSV-1, we conclude that INSM1 induction
plays a positive role in viral replication. It is well known
that ICP0 is sufficient to trigger HSV reactivation in
latently infected trigeminal ganglion neurons. INSM1
may be involved as a host factor in the reactivation of
HSV latency. We are now investigating the roles of
INSM1 in the HSV life cycle in a mouse model system.
Methods
Cells and viruses
Vero cells derived from a stable African monkey kidney
were propagated in Eagle’s minimal essential medium
(EMEM) containing 10% calf serum. HEp-2 cells derived
from a human laryngeal carcinoma were propagated in
Dulbecco’s modified Eagle medium (DMEM) containing
10% fetal calf serum (FCS). HaCaT, a human keratino-
cyte cell line, was kindly provided by Dr. Norbert E
Fusenig (German Cancer Resarch Center, Heidelberg,
Germany) [40]. HaCaT cells were propagated in DMEM
containing 5% FCS. SBC-3 cells derived from a human
small-cell lung carcinoma were propagated in EMEM
containing 10% FCS (provided by Health Sciences
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NHEK of neonatal foreskin (NHEK(F)) was obtained
from Kurabo (Osaka, Japan) and subcultured in Hume-
dia-KB2 medium (Kurabo) supplemented with bovine
pituitary extract (0.4% v/v), human epidermal growth
factor (0.1 ng/ml), insulin (10 μg/ml), hydrocortisone
(0.5 μg/ml), gentamycin (50 μg/ml), and amphotericin B
(50 ng/ml) (Complete Humedia-KG2). All viruses were
propagated and titered on Vero cells. The WT HSV-1
strain F and its ΔUS3 mutant R7041 were kindly pro-
vided by B. Roizman, University of Chicago. The proper-
ties of the WT HSV-2 strain 186 and its ΔUS3 mutant
L1BR1 have been described [41]. Viruses were propa-
gated in Vero cells by infection at a low MOI (0.01
PFU/cell), and infected cells and growth medium were
harvested together when almost all cells showed cyto-
pathic effects. Virus stocks were prepared by one cycle
of freezing and thawing followed by centrifugation at
3,000 rpm for 5 min at 4°C to remove cell debris, and
then stored at -80°C. Virus stock titers were determined
on Vero cells by plaque assay. Subconfluent NHEK cells
plated in 10-cm dishes were mock-infected or infected
with HSV-1 (F, R7041) or HSV-2 (186, L1BR1) (3 PFU/
cell) for 60 min at 37°C, followed by the addition of
DMEM containing 1% FCS.
RNA isolation
At the indicated times after infection, the medium was
removed and cells were washed with PBS and then lysed
with ISOGEN reagent (Nippon Gene Co., Toyama,
Japan). Lysates were stored at -80°C. RNA for microar-
ray analysis was isolated with Isogen and purified using
the RNeasy MinElute kit (Qiagen, Valencia, CA, USA)
according to the manufacturer’s instructions. RNA qual-
ity was assessed using an Agilent 2100 Bioanalyzer (Agi-
lent Technologies, Palo Alto, CA). Double-stranded
cDNA was synthesized using a T7-oligo (dT) primer
and the One-cycle cDNA synthesis kit (Affymetrix Inc.,
S a n t aC l a r a ,C A )a n ds u b s e q u e n t l yp u r i f i e du s i n ga
Sample Cleanup Module (Affymetrix).
Microarray data analysis
Hybridization samples were prepared and processed
according to the GeneChip Expression Analysis Techni-
cal Manual, 701021 Rev. 5. The Human Genome U133
plus 2.0 chips comprise 54,765 probe sets. Data were
analyzed using the GeneChip Operating Software ver-
sion 1.4 (Affymetrix 690036) according to the GeneChip
Expression Analysis Data Analysis Fundamentals. Using
DNA MicroArray Viewer (Kurabo, Osaka, Japan), fold
changes in expression between each of the infected sam-
ples compared with mock-infected controls of the same
cell type were calculated (log2 transformed) and further
classified as unchanged, increased (signal log ratio
change P value of < 0.005), decreased (signal log ratio
change P value of > 0.995), or marginally increased or
decreased. Sequences that showed differential expression
in infected cells were grouped according to the Gen-
eOntology terms for biological processes, available on
the National Center for Biotechnology Information web-
site (March 2006, NCBI Build 36.1). Sequences not yet
annotated by GeneOntology were not analyzed further.
Genes that could be placed into more than 1 group
according to these annotations were arbitrarily assigned
to a single group.
RT-PCR analysis
INSM1 mRNA levels were determined by RT-PCR. To
ensure the absence of genomic DNA contamination, the
samples were tested by PCR without RT. First-strand
cDNA was prepared from 1 μg total RNA using the Pro-
mega reverse transcription system (Promega, Madison,
Wisconsin, USA, A3500), and cDNA was used as a PCR
template for TaKaRa Ex Taq (TAKARA BIO INC,
Shiga, Japan, RR001A). The PCR conditions were as fol-
lows: 98°C for 10 s, 58°C for 30 s, and 72°C for 30 s.
The primers used were as follows: human INSM1, (for-
ward) 5′-AACTGTGCCTTCGCTTGGA-3′ and (reverse)
5′-ACGAGACAAACGCGTACAGCT-3′ (269-bp pro-
duct); human GAPDH, (forward) 5′-CGGAGTCAACG-
GATTTGGTCGTAT-3′ and (reverse) 5′-AGCCTTC
TCCATGGTGGTGAAGAC-3′ (307-bp product).
Plasmids and constructs
Human INSM1 cDNA was amplified from SBC3 cells by
PCR using specific primers (forward, 5′- GCCGGATC-
CAACATGCCCCGCGGCTTCCTGGTGAA -3′; reverse,
5′- CGGAATTCCAGCAGGCCGGGCGCACGGG-3′)
and KOD FX (TOYOBO, Osaka, Japan, KFX-101). The
P C Rc o n d i t i o n sw e r ea sf o l l o ws: denaturation at 94°C
for 2 min, 35 cycles of denaturation at 98°C for 10 s,
and extension at 68°C for 1 min 30 s. The PCR products
were electrophoresed on a 1.5% agarose gel, and frag-
ments were extracted using a QIAquick Gel Extraction
kit (Qiagen). These extracted fragments were amplified
by PCR under the abovementioned conditions using
specific primers containing BamHI and EcoRI sites. The
PCR products were digested with BamHI and EcoRI and
cloned into the respective cognate sites of pEF-mycHisB
(Invitrogen, Carlsbad, CA, USA). cDNA fragments of
INSM1 mutants were amplified from full-length. pEF-
INSM1-C was constructed using PCR on this template
with primers (forward, 5′-CGGGATCCAACATG-
GAGGGCCCGGTGGAG-3′ and reverse, 5′- CGGAAT
TCCAGCAGGCCGGGCGCACGGG-3′)f o l l o w e db y
substitution of a BamHI-a n dEcoRI-restricted amplified
fragment. pEF-INSM1-N was constructed using PCR
with a reverse primer 5′-CGGAATTCACCGGGCCC
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sion vector pCDNA-HSV-1 UL48 has been described
[42]. The complete coding sequences of all constructs
were verified by sequencing.
Transfection and infection
Cells were plated on 35-mm dishes and incubated for 24
h before transfection or infection. Cells were transfected
with 1 μg of each plasmid DNA using FugeneHD
(Roche Applied Science, Indianapolis, IN, USA,
04709705001) according to the manufacturer’s recom-
mendations. In some experiments, transfected cells were
also infected with HSV-1(F) 20-24 h after transfection.
Infections were performed by exposing cells to a mini-
m a lv o l u m eo fv i r u sd i l u t e da tM O Io f3P F U / c e l li n
EMEM without FCS. After 1 h of adsorption, the virus
inoculum was replaced with DMEM containing 1% FCS
and cells were incubated for the indicated time periods.
Immunofluorescence confocal microscopy
Indirect immunofluorescence confocal microscopy was
performed as previously described with modifications
[42]. In brief, cells grown on cover slips were fixed in
4% paraformaldehyde in PBS for 20 min and permeabi-
lized with 0.5% Triton X-100 for 5 min at room tem-
perature. Coverslips were incubated for 1 h at 37°C
sequentially with 20% normal goat serum (DAKO,
Glostrup, Denmark) and primary and secondary antibo-
dies (30 min for each). The following primary antibodies
were used: polyclonal anti-Myc (1:100 dilution; Santa
Cruz Biotechnology, Inc., sc-40) and anti-INSM1 (1:100
dilution; Abcam, ab30940) antibodies; monoclonal anti-
ICP0 (1:100 dilution; Virusys, H1A027-100) and anti-
ICP8 (1:50 dilution; Abcam, ab20194) antibodies. FITC-
or TRITC-conjugated goat anti-rabbit and anti-mouse
antibodies were used as secondary antibodies. In some
experiments, coverslips were additionally incubated with
DRAQ5™ (1:4,000, Biostatus, Leicestershire, UK) for 30
min at room temperature to stain nuclear DNA together
with secondary antibody staining. For double staining
with two different mouse monoclonal antibodies, mouse
anti-Myc and anti-ICP0 or anti-ICP8 antibodies were
directly conjugated with AlexaFluor 488 and 555,
respectively, using the Zenon Mouse IgG1 labeling kit
(Molecular Probes, Eugene, OR, Z25002 and Z25005)
according to the manufacturer’s protocol, and cells were
incubated sequentially with each antibody. Confocal
images were captured using the Zeiss LSM510 system
(Carl Zeiss, Jena, Germany). Images were acquired and
processed using Adobe Photoshop Elements 7.
Luciferase Reporter Assay
To generate luciferase reporter plasmids of the human
INSM1 promoter, PCR fragments (-441 to +26 bp)
from the HEp-2 genome were inserted into the KpnI
and XhoI sites of the pGL3 basic luciferase expression
vector (Promega, #E1751). To generate luciferase
reporter plasmids of the HSV-1 ICP0 promoter, PCR
fragments (-834 to +145 bp) from the HSV-1(F)-
infected HEp-2 genome were inserted into the KpnI
and XhoI sites of the pGL3 basic luciferase expression
vector. Using FugeneHD, HEp-2 or HaCaT cells were
transfected with luciferase reporter plasmids and
INSM1 expression plasmids according to the manufac-
turer’s instructions. The cells were plated in 48-well
plates and transfected with expression vectors and a
reporter gene. HEp-2 or HaCaT cells in 48-well plates
were transfected into cells at 30-40% confluence. Tri-
plicate wells received 100 ng of reporter plasmid and
5-50 ng of expression vector DNAs, and cells were
harvested for luciferase assays after 24 h. HEp-2 or
HaCaT cells were cultured in 48-well microplates and
transfected with 100 ng of hINSM1-Luc or ICP0-Luc
reporter plasmids and the desired expression plasmids
(5-50 ng of each expression plasmid). The total
amount of plasmid DNA was kept constant by balan-
cing with the empty vector. Transfection mixtures
were added dropwise into cell culture medium and
i n c u b a t e da t3 7 ° Cf o r4 8h .T r a n s f e c t e dc e l l sw e r eh a r -
vested in PBS and lysed with 50-70 μlo f1×p a s s i v e
lysis buffer (Promega, E1941). Cell lysates were clari-
fied by centrifugation and assayed for luciferase activity
using the luciferase assay system (Promega, E1483).
Luciferase activity was normalized by protein concen-
tration of each sample, which was determined by the
Bio-Rad Protein assay kit (BIO-RAD, #500-0006).
ChIP assay
Forty-eight hours after transfection, transfectants were
infected with HSV-1(F) at MOI of 3 PFU/cell 7 h post-
infection. The cells were fixed by adding formaldehyde
to the medium (1% final concentration) for 15 min at
room temperature. The cross-linking reaction was ter-
minated by adding glycine to a final concentration of
0.125 M. The fixed cells were washed twice in ice-cold
PBS and solubilized in SDS lysis buffer (1% SDS, 10
mM EDTA, 50 mM Tris-HCl, pH 8.0) containing pro-
tease inhibitor cocktail (Sigma-Aldrich), and 10 μM
PMSF for 20 min on ice. The chromatin complexes
w e r es h e a r e db ys o n i c a t i o nt oa na v e r a g ef r a g m e n ts i z e
of 200-500 bp. Sonication was performed with Bioruptor
(Cosmo bio co., Ltd., Tokyo, Japan), using 100 μli n1 . 5
ml tube. One time of sonication was done with 30 s on
a n d3 0so f fw i t hh i g hp o w e r .T e nt i m e so fs o n i c a t i o n
were performed with 10 min. ChIP assays were per-
formed using the OneDay ChIP assay kit (Diagenode,
Nippon Gene 313-86401) according to the manufac-
turer’s protocol. Cells were lysed in SDS lysis buffer (1%
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ing protease inhibitor cocktail (Sigma-Aldrich) and 10
μM PMSF and then sonicated. Chromatin solution was
subjected to immunoprecipitation using a OneDay ChIP
kit (Diagenode, Sparta, NJ) according to the manufac-
turer’s instructions. The following antibodies were used:
anti-Myc (Santa Cruz Biotechnology, Inc., sc-789) and
negative control rabbit IgG (contained in the OneDay
ChIP assay kit). The HSV-1 ICP0 promoter was ampli-
fied by PCR using the following primers: (forward) 5′-
AAGCCCCTGTTGCGTCGGCG-3′ and (reverse) 5′-
TTATCCCCACGCCTTTCCC-3′ (234 bp). As a nega-
tive control, the HSV-1 ICP27 promoter was amplified
using the following primers: 5′-GGGGTACCCCCAAC-
GACCCCGCCCATGGG-3′ and 5′-GGCTCGAGG
GGGTGTCGGATATCGCCTCT-3′ (396 bp).
Gene Silencing
To knock down INSM1 expression, HEp-2 cells were
transfected with an INSM1-specific siRNA (5′-UCCG-
CAAGCUGCACUUCGATT-3′)o ras c r a m b l e d( 5 ′-
GCAUUCCAUCGCGCGGUCACATT-3′)( 2 0μM; Nip-
pon EGT Co., Ltd.) ribooligonucleotide using X-treme-
GENE siRNA transfection reagent (Roche,
#04476093001). At 24 h after siRNA transfection, HEp-2
cells were infected with HSV-1(F) at MOI of 1, and total
RNA was extracted 6 h after infection and analyzed by
RT-PCR. At 24 h posttransfection, HEp2 cells were
infected with HSV-1 at MOI of 0.01 PFU/cell at 24 h.
Total protein lysate or culture medium were collected
and analyzed by western blotting or virus titration,
respectively.
Statistics
Data were analyzed by Student’s t test. P <0 . 0 5w a s
considered significant.
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